(Q36065972)

12 August 2017

1 reference

title

From mice to humans - murine intelligence for human CD8+ T cell vaccine design (English)

1 reference

12 August 2017

1 reference

2

Andreas Suhrbier

1 reference

12 August 2017

David C Tscharke

1

0 references

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

263-271

1 reference

The value of vaccination: a global perspective

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Measles vaccination improves the equity of health outcomes: evidence from Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Vaccines for the prevention of diseases caused by potential bioweapons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Viral vectors for inducing CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Applications of pox virus vectors to vaccination: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Alphavirus vectors for vaccine production and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Bacterial ghosts are an efficient delivery system for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Peptides identified through phage display direct immunogenic antigen to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Current vaccine adjuvants: an overview of a diverse class

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Use of CpG oligodeoxynucleotides as immune adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

TLR7: A new sensor of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

21 January 2018

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Helping the CD8(+) T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD8+ T-cell memory: only the good ones last

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Environmental conservation: bystander CD4 T cells keep CD8 memories fresh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Helper requirements for generation of effector CTL to islet beta cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD4+ CD25+ Treg: divide and rule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Antigen-specific regulatory T cells--their induction and role in infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD8+ T cell contraction is controlled by early inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

DNA vaccines: influenza virus challenge of a Th2/Tc2 immune response results in a Th2/Tc1 response in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Spinning molecular immunology into successful immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Therapeutic dendritic-cell vaccine for simian AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.263

21 January 2018

Identifiers

DOI

10.1517/14712598.5.2.263

1 reference

12 August 2017

1 reference